Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported):   June 18, 2013

SafeStitch Medical, Inc.
(Exact name of registrant as specified in its charter)

Delaware 0-19437 11-2962080
(State or other jurisdiction
(I.R.S. Employer
of incorporation) File Number) Identification No.)
4400 Biscayne Blvd., Miami, Florida   33137
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code:   305-575-4600

Not Applicable
Former name or former address, if changed since last report


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

ITEM 5.07. Submission of Matters to a Vote of Security Holders.

At the Annual Meeting of Stockholders of SafeStitch Medical, Inc. (the “Company”) held on June 18, 2013, the Company’s stockholders considered one proposal.

Proposal 1 – Election of seven members to the Company’s Board of Directors to serve until the 2014 Annual Meeting of Stockholders.

    The results of the voting were as follows:
Election of Directors   For   Withheld
Jane H. Hsiao, Ph.D.
    51,106,119       90,097  
Jeffrey G. Spragens
    51,194,590       1,626  
Charles J. Filipi, M.D.
    51,194,590       1,626  
Chao C. Chen, Ph. D.
    51,191,490       4,726  
Richard C. Pfenniger. Jr.
    51,194,590       1,626  
Steven D. Rubin
    51,106,119       90,097  
Kevin T. Wayne, D.B.A.
    51,194,590       1,626  

    Based on the votes set forth above, the director nominees were duly elected.

There were no broker non-votes for this proposal. No other matters were considered or voted upon at the meeting.


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    SafeStitch Medical, Inc.
June 18, 2013   By:   James J. Martin
        Name: James J. Martin
        Title: Chief Financial Officer